PET-Plan: potential for dose escalation by target volume reduction in locally advanced NSCLC.
作者信息
de Jong Evelyn E C, van Timmeren Janita E
机构信息
Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands.
Department of Radiation Oncology, University Hospital Zürich and University of Zürich, Zürich, Switzerland.
出版信息
Transl Lung Cancer Res. 2020 Aug;9(4):1595-1598. doi: 10.21037/tlcr-20-653.
Abstract
摘要
相似文献
1
PET-Plan: potential for dose escalation by target volume reduction in locally advanced NSCLC.PET-计划：局部晚期非小细胞肺癌中通过缩小靶体积提高剂量的潜力。
Transl Lung Cancer Res. 2020 Aug;9(4):1595-1598. doi: 10.21037/tlcr-20-653.
2
Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy.肿瘤运动补偿和勾画方法对非小细胞肺癌放射治疗中基于氟代脱氧葡萄糖正电子发射断层扫描的剂量描绘计划质量的影响。
J Med Imaging Radiat Oncol. 2018 Feb;62(1):81-90. doi: 10.1111/1754-9485.12693. Epub 2017 Nov 28.
3
F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.F-18-FDG-PET 引导下的局部晚期 NSCLC 同期放化疗：PET-PLAN 先导试验结果。
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e283-9. doi: 10.1016/j.ijrobp.2011.01.020. Epub 2011 Apr 4.
4
Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer.在局部晚期非小细胞肺癌放疗期间使用连续四维正电子发射断层扫描/计算机断层扫描进行自适应剂量递增
Clin Oncol (R Coll Radiol). 2016 Dec;28(12):e199-e205. doi: 10.1016/j.clon.2016.08.011. Epub 2016 Sep 13.
5
FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.氟代脱氧葡萄糖（FDG）和氟[18F]代甲氧异腈（FMISO）正电子发射断层扫描（PET）指导下的肺癌强度调制放疗（IMRT）剂量递增。
Radiat Oncol. 2018 Oct 23;13(1):208. doi: 10.1186/s13014-018-1147-2.
6
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.基于影像学的局部晚期非小细胞肺癌放化疗靶区缩小（PET-Plan）：一项多中心、开放标签、随机、对照试验。
Lancet Oncol. 2020 Apr;21(4):581-592. doi: 10.1016/S1470-2045(20)30013-9. Epub 2020 Mar 12.
7
Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.自适应放疗在局部晚期非小细胞肺癌同期放化疗中增加剂量的潜力。
Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):901-8. doi: 10.1016/j.ijrobp.2010.04.050. Epub 2010 Aug 12.
8
IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.局部晚期非小细胞肺癌中调强放疗与三维适形放疗联合或不联合选择性淋巴结照射：基于PET的治疗计划的直接比较
Strahlenther Onkol. 2016 Feb;192(2):75-82. doi: 10.1007/s00066-015-0900-9. Epub 2015 Oct 5.
9
Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?对于III期非小细胞肺癌患者，在放疗的第5至6周进行额外的PET/CT检查作为剂量递增计划的一种手段？
Radiother Oncol. 2008 Sep;88(3):335-41. doi: 10.1016/j.radonc.2008.05.004. Epub 2008 May 29.
10
Potential for adaptive dose escalation in radiotherapy for patients with locally advanced non-small-cell lung cancer in a low mid income setting.中低收入环境下局部晚期非小细胞肺癌患者放疗中适应性剂量递增的潜力
Br J Radiol. 2017 Feb;90(1070):20140234. doi: 10.1259/bjr.20140234. Epub 2017 Jan 3.
本文引用的文献
1
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.基于影像学的局部晚期非小细胞肺癌放化疗靶区缩小（PET-Plan）：一项多中心、开放标签、随机、对照试验。
Lancet Oncol. 2020 Apr;21(4):581-592. doi: 10.1016/S1470-2045(20)30013-9. Epub 2020 Mar 12.
2
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial).随机 II 期剂量递增试验在非小细胞肺癌中的急性和晚期毒性结果（PET-boost 试验）。
Radiother Oncol. 2019 Feb;131:166-173. doi: 10.1016/j.radonc.2018.09.019. Epub 2018 Oct 13.
3
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.早期和局部晚期非小细胞肺癌（NSCLC）：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21. doi: 10.1093/annonc/mdx222.
4
European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer.欧洲癌症研究与治疗组织（EORTC）关于肺癌高剂量、高精度放射治疗的计划和实施建议。
Radiother Oncol. 2017 Jul;124(1):1-10. doi: 10.1016/j.radonc.2017.06.003. Epub 2017 Jun 27.
5
Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.局部晚期非小细胞肺癌患者接受同期适形分割放化疗联合或不联合西妥昔单抗的长期随访。
Radiother Oncol. 2016 Mar;118(3):442-6. doi: 10.1016/j.radonc.2016.02.011. Epub 2016 Feb 15.
6
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.标准剂量与高剂量适形放疗联合并巩固使用卡铂加紫杉醇，联合或不联合西妥昔单抗治疗IIIA期或IIIB期非小细胞肺癌患者（RTOG 0617）：一项随机、二乘二析因3期研究。
Lancet Oncol. 2015 Feb;16(2):187-99. doi: 10.1016/S1470-2045(14)71207-0. Epub 2015 Jan 16.
7
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.正电子发射断层显像-计算机断层扫描用于评估疑似可切除非小细胞肺癌患者的纵隔淋巴结受累情况。
Cochrane Database Syst Rev. 2014 Nov 13;2014(11):CD009519. doi: 10.1002/14651858.CD009519.pub2.
8
The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer.PET-boost 随机 2 期剂量递增试验在非小细胞肺癌中的应用。
Radiother Oncol. 2012 Jul;104(1):67-71. doi: 10.1016/j.radonc.2012.03.005. Epub 2012 Apr 6.
9
Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma.定义局部区域控制及其在局部晚期非小细胞肺癌中的重要性。
J Thorac Oncol. 2012 Apr;7(4):716-22. doi: 10.1097/JTO.0b013e3182429682.
10
Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.序贯与同步放化疗治疗 III 期非小细胞肺癌：RTOG9410 随机 III 期试验
J Natl Cancer Inst. 2011 Oct 5;103(19):1452-60. doi: 10.1093/jnci/djr325. Epub 2011 Sep 8.
Zotero 插件